Our DNA Sequencing Cores are at Baylor College of Medicine and HudsonAlpha Institute for Biotechnology with Illumina. Below is the original NIH award announcement, prior to the principal investigators’ relocation to HudsonAlpha from the Medical College of Wisconsin.
Baylor College of Medicine, Medical College of Wisconsin to conduct DNA sequencing for Undiagnosed Diseases Network
Additional UDN grants will fund studies to learn the role of gene variants in undiagnosed diseases
The National Institutes of Health (NIH) announced today that Baylor College of Medicine in Houston and the Medical College of Wisconsin in Milwaukee will be providing DNA sequencing for the Undiagnosed Diseases Network (UDN). Each site will receive more than $2.5 million over four-years, pending availability of funds.
These two universities will become the DNA Sequencing Core sites for the UDN. The UDN also includes seven clinical sites at academic medical centers and at the NIH, as well as a coordinating center operated by Harvard Medical School in Boston.
The UDN, based on a pilot program launched in 2008 at the NIH Clinical Center in Bethesda, Maryland, is developing approaches for the diagnosis of difficult-to-solve medical cases. Along with traditional methods, doctors pursue medical diagnoses for patients by analyzing DNA sequence, which can reveal variants in patients’ genome that may be the cause of a disease. Genome sequencing is an increasingly fast and inexpensive technology that only recently has been used for patient diagnosis.